Novartis | pharmaphorum

Thursday 24 September 2026

Novartis

News

Novartis HQ

Novartis buys neurology biotech AveXis for $8.7bn

Novartis has bought biotech AveXis for $8.7 billion, adding a potential gene therapy for the rare disease spinal muscular atrophy (SMA) to its pipeline.

News

gskhouse2

GSK to pay $13bn for Novartis stake in OTC joint venture

GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to fund the £9.2 billion ($13bn) acquisition.

Views & Analysis

Theranos_PaloAlto_HQ_1

Digital health round-up: Theranos' Holmes charged with 'mass...

Richard Staines gives a weekly round-up of the developments in digital health

Digital

Novartis HQ

Novartis' new digital chief joins exec committee

Incoming CEO Vas Narasimhan continues digital health push

Views & Analysis

digital-network

Digital Health Round-Up: Novartis and Science 37 hope to cut...

Richard Staines presents a round-up of the week’s digital health news

News

Novartis-AU-HQ

Novartis expands virtual clinical trial project with Science...

Swiss pharma builds on existing collaboration with Science 37